ABOUT CLASS MEDICAL

Dr. Rory Mooney has held senior engineering roles with two large medical devices companies over the last 30 years at Lake Region Medical Ltd. (Integer Corp) and Stryker Innovations, EMEA commercialising new technologies. Dr. Mooney has also worked as an academic in Mechanical and Biomedical Engineering, in both the University of Limerick and Atlantic Technological University. Dr. Mooney was the founding CEO of Class Medical, leading the company through the Seed round of investment.

Dr Mooney has successfully led the company in obtaining ISO13485 accreditation and the CE Mark for the TUCSV.

Mr. Danny Forde is the Chief Executive Officer of Class Medical. He was appointed to the role in June 2025, having previously joined the company as Director of Business Development in August 2024. Mr. Forde brings more than 15 years of industry experience and a strong track record of driving growth and innovation from his time at Bio-Medical Research, Atlantic Therapeutics, and Caldera Medical. Mr. Forde holds a Masters in Business Administration from the University of Limerick. He is deeply passionate about advancing patient safety and is leading Class Medical's mission to establish its unique and patented Trans Urethral Catheter Safety Valve as the global standard of care for urinary catheterisation, aiming to eliminate the risk of catheter balloon injuries.

Mr. Niall Davis is a graduate of University College Dublin, Ireland and undertook basic surgical training with the Royal College of Surgeons Ireland (RCSI). He completed his Higher Surgical Training in urology in 2017 and completed his fellowship in minimally invasive urological surgery in Melbourne in 2019. He is a senior lecturer for the RCSI and works as a consultant urologist in Beaumont and Connolly Hospitals. Mr Davis teamed up with researchers Dr Rory Mooney and Professor Michael Walsh of the University of Limerick to help develop the transurethral catheter safety valve for preventing transurethral catheterisation injury. Mr Davis has also completed a PhD in tissue-engineering in the University of Limerick and has >100 publications in indexed medical journals. Mr Davis continues to work with his biomedical engineering colleagues in Ireland to develop and commercialise his research interests.

Prof Walsh is an experienced biomedical engineer and an expert in the field of fluid mechanics.  He is a founding member of the Centre for Applied Biomedical Engineering Research (CABER) Limerick, Ireland and responsible for raising over €5M in funding. Prof Walsh is an Associate Professor in the School of Engineering and a member of both the Bernal Institute and the Health Research Institute.  He is well published in both medical and engineering fields (75 peer-reviewed journal papers). His current research team includes 8 PhD students and 2 post-doctoral students. He has supervised to completion 17 PhD students and 22 MSc students. He holds 2 granted patents as lead inventor, 8 further patent applications, 12 Invention Disclosures, a royalty bearing license of technology to indigenous Irish company and 2 technologies selected for EI Business Partner program.

Mr. O’Shiel has over 44 years experience in financial services. The last 20 of these were as Senior Vice President and Chief Financial Officer of Chubb Insurance company of Europe. Since retiring in 2012 he has served on the European insurance company’s board as a Non-Executive Director, before stepping down in 2018 to focus on other projects, serving as CEO of Class Medical from that time until early 2025. Mr. O’Shiel has also been active as an investor in a number of early stage start-up companies over the last ten years, two of which have resulted in successful exits with other portfolio companies seeing strong revenue growth. He invests his time along with his funds.

Mr. Hugh Flood is an academic Urologist since 1991 with a particular interest in Female and Reconstructive Urology. He was a Fellow with Professor Edward McGuire at the University of Michigan Medical Centre and has an MCh in Neuropharmaco/physiology. Previous appointments include Associate Professor of Urology at the University of Pittsburgh Medical Centre and Head of Urology at University Hospital Limerick. He was PI on an NIH RO1 grant (€650k) while at UPMC. He has supervised a number of MCh/PhD medical theses at UL and UCC including an HRB grant-funded study (€250k) at UL awarded to Dr. Niall Kelly. With almost 100 publications, Mr. Flood is a reviewer for a number of the major Urology journals and works as a Urology medicolegal claims expert for the State Claims Agency and the Medical Protection Society.

Mr Wood has 35 years experience encompassing Wealth Management and General Insurance most recently as Chief Financial Officer and Chief Operating Officer at Quilter Investment Platform. Before that he served as European Chief Financial Officer for Chubb Insurance Company and Finance Director for the UK General Insurance arm of American International Group (AIG). He is currently Independent Non Executive Director and Chair of the Risk Committee for CNA Hardy, a specialty insurer operating across Europe and at Lloyd’s of London. He is an investor in Class Medical as well as in a number of other early stage businesses in the UK.

Tim O’Connor (B.Eng., Manufacturing Engineering) has accumulated over 30 years experience in manufacturing companies, working as a Toolmaker/Manufacturing Engineer in regulated industries such as medical devices, automotive , mobile devices, consumer, electrical and industrial, with the last 10 years in medical devices. 

Ray McEvoy (B.Eng, M.Eng.Sc, M.Sc (Mgmt)) is responsible for Quality & Regulatory affairs as well as being QMS Mgmt Rep & PRRC within Class Medical. He has accumulated 40 years experience in design and manufacturing companies in the regulated industries such as Medical Devices, Pharma, Aerospace and Automotive. He has worked with Class Medical since 2017 and has implemented and developed the ISO 13485 Quality Management System, that has been certified by NSAI.  He has guided medical device organisations from start-up through initial product launch to self-certification of Class 1 medical devices per MDD 93/42 and to FDA registration. As well as a strong regulatory background, he is also a certified Lean Enterprise Expert, 6-Sigma Greenbelt and has facilitated or participated in process improvement programs in the USA, Germany, France, UK, as well as Ireland.

Susan has 20 years experience in retail at various levels of seniority. She is now a motivated member of our team bringing a wealth of organisation experience and positivity, dealing with the day to day tasks, sales orders, accounts and warehousing.

Mary Corridan joined the Class Medical board in May 2025, bringing extensive
experience in scaling healthcare services and medical recruitment. As the former
Managing Director and Chair of Health Harmonie, Mary transformed the organization
from a specialized clinic into a leading nationwide provider of community services,
eventually overseeing its sale to Medinet in 2024. Her entrepreneurial background
also includes founding BML Medical Recruitment, where she led international
recruitment campaigns and grew the business to a multi-million-pound turnover. A
graduate of the Goldman Sachs 10,000 Small Businesses program, Mary provides
Class Medical with deep strategic insight into the UK and international healthcare
markets.

David Kaysen joined the Class Medical board in May 2025 with over 40 years of
executive leadership experience in the global medical device and biotechnology
sectors. David has a proven track record of driving commercial success, notably
leading Rehabilicare through a period of significant growth from $4 million to over
$75 million in revenue. Throughout his career, he has raised more than $100 million
in capital and successfully navigated complex FDA approval and reimbursement
processes for numerous emerging growth companies. Currently serving as the CEO
of SubioMed and Chairman of InterRad Medical, David’s expertise in international
market expansion and strategic mergers is a vital asset to the Class Medical
leadership team.